Antitetanus vaccination and neonatal protection in developing countries.
D000293:Adolescent; D000327:Adsorption; D000907:Antibodies, Bacterial / Q000032:analysis; D000992:Antitoxins / Q000032:analysis / Q000096:biosynthesis; D002130:Calcium Phosphates; D002648:Child; D002675:Child, Preschool; D003906:Developing Countries; D005260:Female; D006801:Humans; D007114:Immunization; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D011247:Pregnancy; D013742:Tetanus / Q000517:prevention & control*; D013745:Tetanus Toxoid / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D014611:Vaccination
D000907:Antibodies, Bacterial; D000992:Antitoxins; D002130:Calcium Phosphates; D013745:Tetanus Toxoid